CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: Optimal Pacing Rate for Cardiac Resynchronization Therapy [NA]
Summary
Sponsored by Medstar Health Research Institute, this trial investigates the optimal pacing rate for cardiac resynchronization therapy in patients with persisten…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medstar Health Research Institute | Conditions: Atrial Fibrillation, Persistent | NA | Status: RECRUITING